Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

21.40
-0.4900-2.24%
Post-market: 21.27-0.1341-0.63%19:30 EDT
Volume:3.73M
Turnover:79.81M
Market Cap:1.27B
PE:1.86
High:22.00
Open:21.92
Low:21.23
Close:21.89
52wk High:49.95
52wk Low:6.50
Shares:59.16M
Float Shares:37.23M
Volume Ratio:3.41
T/O Rate:10.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.53
EPS(LYR):-70.5015
ROE:-125.43%
ROA:-21.37%
PB:-6.32
PE(LYR):-0.30

Loading ...

Mar 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 07, 2022

Major Issues Report

8-K - Current report
Dec 07, 2022

Major Issues Report

8-K - Current report
Nov 29, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans